A Prospective Study of the Relationship among Asthma and COPD Phenotypes, Endotypes, and Genotypes for Personalized Medicine

A Prospective Study of the Relationship among Asthma and COPD Phenotypes, Endotypes, and Genotypes for Personalized Medicine - A-SCOPE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016694

Enrollment

300

Registered

2015-03-05

Start date

2015-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma COPD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical diagnosis of asthma and/or COPD Patients receiving current drug therapy in asthma or COPD have no change in drug treatment during 8-week

Exclusion criteria

Exclusion criteria: Patients who have received anticancer agents within the last 6 months Patients undergoing immunosuppressive therapy with steroids such as in diseases other than asthma or COPD Patients suffering from infection or patients with infection is suspected

Design outcomes

Primary

Measure	Time frame
Exacerbation of asthma or COPD within one year	—

Secondary

Measure	Time frame
symptom scores, lung function, fractional exhaled nitric oxide,	—

Countries

Japan

Contacts

Public ContactKeita Hirai

University of Shizuoka Department of clinical pharmacology and genetics, school of pharmaceutical science

hiraik@u-shizuoka-ken.ac.jp054-264-5674

Outcome results